COVID-19 vaccine

Health & Safety

Novavax Posts Coronavirus Vaccine Contract That Government Didn't Disclose

4:00pm November 11, 2020

by Sydney Lupkin

The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.

Gen. Gustave Perna tells NPR that if a safe and effective COVID-19 vaccine is approved by the Food and Drug Administration in December, "10 to 30 million doses of vaccine will be available that we can start distributing" in the United States.

Operation Warp Speed's Logistics Chief Weighs In On Vaccine Progress

9:35pm November 09, 2020

by Pien Huang

Gen. Gustave Perna says as soon as the FDA deems a vaccine safe and effective, his team is ready to coordinate deployment of tens of millions of doses as early as next month.

Pfizer said a clinical trial of its experimental COVID-19 vaccine found it to be more than 90% effective.

Health & Safety

Pfizer Says Experimental COVID-19 Vaccine Is More Than 90% Effective

5:14pm November 09, 2020

by Joe Palca

Pfizer's COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.

Queue Listen Now

The Department of Health and Human Services on Saturday made public several contracts with companies working on COVID-19 vaccines as part of Operation Warp Speed.

Health & Safety

HHS Released More Coronavirus Vaccine Contracts As Election Results Unfolded

2:16pm November 08, 2020

by Sydney Lupkin

Newly released COVID-19 vaccine contracts include weakened protections against potential price gouging. Several key federal contracts still haven't been disclosed by the government.

Moncef Slaoui, a former GlaxoSmithKline executive, speaks during the kickoff announcement for Operation Warp Speed in the White House Rose Garden on May 15.

Health & Safety

After Months Of Questions, A Key Operation Warp Speed Adviser's Contract Emerges

12:38am October 31, 2020

by Sydney Lupkin

Drug industry veteran Moncef Slaoui is a key figure in Operation Warp Speed's push to develop COVID-19 coronavirus vaccines. His employment terms raised concerns about potential conflicts of interest.

Queue Listen Now

Tony Potts, a 69-year-old retiree living in Ormond Beach, Fla., receives his first injection earlier this year as a participant in a Phase 3 clinical trial of Moderna's COVID-19 candidate vaccine.

Advisers To CDC Debate How COVID-19 Vaccine Should Be Rolled Out

9:41pm October 30, 2020

In advance of a COVID-19 vaccine being available, a group of independent medical advisers to the Centers for Disease Control and Prevention weighed Friday who should get the vaccine first and how.

A heavily redacted supply contract between the federal government and vaccine developer Moderna, headquartered in Cambridge, Mass., was released Friday.

Health & Safety

A Federal Coronavirus Vaccine Contract Released At Last, But Redactions Obscure Terms

6:16pm October 24, 2020

by Sydney Lupkin

Most of the federal contracts with companies involved in the crash program to make COVID-19 vaccines haven't been made public. The lack of disclosure raises questions about accountability.

A panel of advisers to the Food And Drug Administration has raised questions about some aspects of the agency's approach to reviewing COVID-19 vaccines.

Health & Safety

Will FDA Heed Its Outside Experts' Advice On COVID-19 Vaccines?

5:50pm October 23, 2020

by Sydney Lupkin

A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.

A health worker injects a woman during clinical trials for a COVID-19 vaccine last month in Hollywood, Fla.

Researchers Find Doubts About COVID-19 Vaccine Among People Of Color

8:00pm October 22, 2020

by Laurel Wamsley

At a series of listening sessions, participants voiced worries that the development of a COVID-19 vaccine is being politicized and rushed. Public health experts are taking vaccine hesitancy seriously.

The first patient enrolled in Pfizer's COVID-19 vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receives an injection in May.

Health & Safety

Pfizer COVID-19 Vaccine Won't Be Ready By Election Day

1:29pm October 16, 2020

by Richard Harris

Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.